Hera Biolabs Receives AAALAC Accreditation For Exceptional Animal Care
One of the most important parts of the entire drug [...]
Humanized Liver Rodent Models
Overview Humanized liver rat and mice are created by [...]
The OncoRat® Is The Ideal Host For Patient-Derived Xenografts Of Ovarian Cancer Cells
Ovarian cancer is the most lethal gynecological cancer in the [...]
Hera Biolabs Announces Molecular Cancer Therapeutics Publication On Immunodeficient Rats For Oncology Research
Hera Biolabs, the University of Michigan, Case Western Reverse University and other collaborators are announcing a recent publication in the American Association for Cancer Research (AACR) journal, Molecular Cancer Therapeutics, entitled, "Sprague Dawley Rag2-null rats created from engineered spermatogonial stem cells are immunodeficient and permissive to human xenografts."
Breakthroughs In Gene Editing Allow For The Creation Of Superior Preclinical Oncology Models
Gene editing is getting a lot of attention in the [...]
Understanding Transporter-Mediated Drug-Drug Interactions Using Humanized Liver Mice
Pharmaceutical researchers and regulators are increasingly aware of the influence [...]
Humanized Mouse Models Advance Immunotherapeutic Strategies In Treatment Of Type 1 Diabetes
A relatively common autoimmune disease, Type 1 Diabetes (T1D) is [...]
Humanized Mice Allow For Better Understanding Of Interactions Between VACV & Immune System
Cancer is responsible for approximately 8 million deaths worldwide, with [...]
Humanized Mouse Model Allows For Study Of Immune Response To Decellularized ECM Biomaterials
Humanized rodent models have been used extensively for studying autoimmune [...]